Exploring the Therapeutic Potential of Non-Invasive Vagus Nerve Stimulation: A Scoping Review
Abstract
Background: The vagus nerve, a key element of the parasympathetic nervous system, regulates vital processes such as heart rate, digestion, and immune function. Non-invasive Vagus Nerve Stimulation (nVNS) techniques, including transcutaneous auricular (taVNS) and cervical (tcVNS) methods, have emerged as promising alternatives to invasive stimulation. These approaches show potential in treating neurological, psychiatric, and inflammatory disorders. This scoping review evaluates the therapeutic potential of nVNS, synthesizing evidence on its efficacy, applications, and research gaps. In this scoping review, a systematic literature search was performed in PubMed, Scopus, Cochrane Library, and Google Scholar using terms like “non-invasive vagus nerve stimulation”, “taVNS”, and “tcVNS”. Studies exploring nVNS applications in psychiatric, neurological, and inflammatory disorders were included, focusing on clinical outcomes, protocols, and therapeutic impacts. nVNS demonstrates promise in autonomic modulation, reducing symptoms of treatment-resistant depression, anxiety, and inflammatory conditions like rheumatoid arthritis and Crohn’s disease. It also shows potential in managing migraines, cluster headaches, and aiding post-stroke rehabilitation. However, variability in study designs and stimulation protocols limits definitive conclusions.
Non-invasive vagus nerve stimulation is a promising non-pharmacological therapy with diverse applications. Standardized large-scale clinical trials are required to optimize stimulation parameters, ensure long-term safety, and develop robust therapeutic guidelines.